Search Results - "Luecke, Kai"

Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series by Hansen, Sarah, Alduaij, Waleed, Biggs, Catherine M., Belga, Sara, Luecke, Kai, Merkeley, Hayley, Chen, Luke Y. C.

“…Introduction Hemophagocytic lymphohistiocytosis (HLH) is a cytokine storm syndrome associated with mortality rates of up to 88%. Standard therapy with…”
Get full text

Cover Image by Hansen, Sarah, Alduaij, Waleed, Biggs, Catherine M., Belga, Sara, Luecke, Kai, Merkeley, Hayley, Chen, Luke Y. C.

Get full text

Cover Image by Hansen, Sarah, Alduaij, Waleed, Biggs, Catherine M., Belga, Sara, Luecke, Kai, Merkeley, Hayley, Chen, Luke Y. C.

“…The cover image is based on the Research Article Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series by Luke YC…”
Get full text

Management of Malignant Chylothorax with Subcutaneous Octreotide Treatment by Lau, Anthony C W, Hsu, Phoebe Yu Hsuan, Ng, David, Luecke, Kai, Nayar, Shalini

“…There are currently limited published case reports and clinical studies looking at octreotide as a potential therapeutic agent for treating surgery- and…”
Get full text

Probing the mitotic history and developmental stage of hematopoietic cells using single telomere length analysis (STELA) by Hills, Mark, Lücke, Kai, Chavez, Elizabeth A., Eaves, Connie J., Lansdorp, Peter M.

“…In most human somatic cells, telomeres shorten as a function of DNA replication. Telomere length is therefore an indirect measure of the replicative history of…”
Get full text

Management of Malignant Chylothorax with Subcutaneous Octreotide Treatment by Lau, Anthony C. W., Hsu, Phoebe Yu Hsuan, Ng, David, Luecke, Kai, Nayar, Shalini

“…There are currently limited published case reports and clinical studies looking at octreotide as a potential therapeutic agent for treating surgery- and…”
Get full text